Requirement for Abl Kinases in T Cell Receptor Signaling  by Zipfel, Patricia A et al.
Current Biology, Vol. 14, 1222–1231, July 27, 2004, 2004 Elsevier Ltd. All rights reserved. DOI 10.1016/j .cub.2004.07.021
Requirement for Abl Kinases
in T Cell Receptor Signaling
sponse to oxidative stress and DNA damage (reviewed
in [1]).
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2Department of Immunology lapping functions during mouse development [1]. This
is highlighted by the observation that mice with a dele-Duke University Medical Center
Durham, North Carolina 27710 tion of both the Abl1 and Abl2 genes die before embry-
onic day 11; however, mice lacking either Abl1 or Abl2
may survive to adulthood [2]. Analysis of embryos lack-
ing both Abl1 and Abl2 reveals massive apoptosis in allSummary
tissues [2]. Despite the clear impact of loss of both
genes, mice null for c-Abl alone present a variety ofBackground: The c-Abl and Arg proteins comprise a
phenotypes, including perinatal lethality, runting, abnor-unique family of nonreceptor tyrosine kinases that have
mal cranial and splenic architecture, and increased sus-been implicated in the regulation of cell proliferation and
ceptibility to infection [3, 4]. Significantly, c-Abl-deficientsurvival, cytoskeletal reorganization, cell migration, and
mice exhibit splenic and thymic atrophy and reducedthe response to oxidative stress and DNA damage. Tar-
numbers of thymocytes and B-cell progenitors [3]. Thegeted deletion or mutation of c-Abl in mice results in a
reduction of lymphocytes was shown to be cell autono-variety of immune system phenotypes, including splenic
mous [3]. Recent findings show that treatment of Bcr-and thymic atrophy, lymphopenia, and an increased
Abl-positive chronic myelogenous leukemia (CML) pa-susceptibility to infection. However, despite the genera-
tients with the Abl kinase inhibitor STI-571 (Gleevec/tion of these mice over a decade ago, little is known
Imatinib) is associated with immunosuppression in aregarding the mechanisms responsible for these pheno-
subset of patients, possibly due to decreased numberstypes or the immune-related consequences of ablation
of CD4-positive T cells [5].of both the c-Abl and Arg kinases, which are coex-
We and others have demonstrated that B cells frompressed in lymphoid tissues.
c-Abl null or mutant mice exhibit reduced proliferationResults: Here, we report that T cell receptor (TCR) stim-
following stimulation of the B cell receptor (BCR) [1,ulation results in activation of the endogenous Abl ki-
6]. We reported that c-Abl tyrosine kinase activity andnases. We demonstrate that Zap70 and the transmem-
protein levels are elevated in the cytosol following acti-brane adaptor linker for activation of T cells (LAT) are
vation of the BCR. Further, we demonstrated that c-Abltargets of the Abl kinases, and that loss of Abl kinase
associates with and phosphorylates the BCR coreceptoractivity reduces TCR-induced Zap70 phosphorylation
CD19 [6]. Overall, these data suggest that c-Abl playsat tyrosine 319. This correlates with diminished LAT tyro-
a role in signal transduction downstream of the BCR.sine phosphorylation, as well as reduced tyrosine phos-
The mechanisms of signal transduction following BCRphorylation and recruitment of phospholipase C1 to
engagement share remarkable conservation with signal-LAT. Significantly, we show that Abl kinase activity is
ing events downstream of the T cell receptor (TCR) [7].required for maximal signaling leading to transcription
The immunoreceptors lack intrinsic kinase activity, butof the IL-2 promoter, as well as TCR-induced IL-2 pro-
receptor engagement leads to rapid tyrosine phosphor-duction and proliferation of primary T cells.
ylation of the immunoreceptor tyrosine-based activationConclusions: We conclude that the Abl kinases have a
motifs (ITAMs) present in their cytoplasmic tails by therole in the regulation of TCR-mediated signal transduc-
Src family kinases [7]. The phosphorylated ITAMs recruittion leading to IL-2 production and cell proliferation.
the SH2 domain-containing Syk and ZAP70 tyrosine ki-
nases, leading to their activation. The activated Syk/
Introduction ZAP70 and Src kinases phosphorylate a variety of scaf-
fold/adaptor proteins that facilitate the recruitment of
The c-Abl (encoded by the Abl1 gene) and Arg (encoded additional adaptors and enzymes to the activated immu-
by the Abl2 gene) proteins comprise a unique family of noreceptor complex. Stimulation of these proteins and
nonreceptor tyrosine kinases [1]. The kinase activity of their respective pathways ultimately leads to alterations
these proteins is tightly regulated in vivo, and structural in the actin cytoskeleton, transcriptional activation, and
alterations in either gene give rise to oncogenic forms the regulation of cell proliferation and differentiation
of c-Abl or Arg, such as Bcr-Abl, Tel-Abl, and Tel-Arg, [7, 8].
which have been identified in human leukemias [1]. Here, we report that the Abl kinases are activated in T
These two kinases are highly conserved, localize to the lymphocytes following TCR stimulation and are required
membrane, cytoskeleton and cytosol, bind F-actin, and for TCR-dependent transcriptional activation. Using
exhibit F-actin bundling activity (reviewed in [1]). Previ- pharmacological inhibition, as well as lymphocytes de-
ous studies have demonstrated roles for the Abl kinases rived from Abl/Arg-deficient mice, we show that loss of
in the regulation of cell proliferation and survival, cy- Abl kinases led to a reduction in TCR-dependent tyro-
toskeletal reorganization, cell migration, and the re- sine phosphorylation of Zap70 on Y319 and the trans-
membrane adaptor linker for activation of T cells (LAT),
as well as a reduction in the amount of phospholipase*Correspondence: pende014@mc.duke.edu
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Figure 1. Abl Kinases Are Activated Following TCR Stimulation
(A) Jurkat T cells were stimulated with anti-CD3 for the indicated times and lysed. The level of CrkL Y207 phosphorylation was assessed by
immunoprecipitation of CrkL and Western blotting with a phosphospecific antibody (top). Blots were stripped and reprobed with an anti-CrkL
antibody to demonstrate equal loading (bottom).
(B) Jurkat T cells were pretreated with the indicated doses of STI-571 for 1 hr prior to stimulation for 10 min, and Abl activation was measured
as in (A).
(C) Jurkat T cells were stimulated as in (A), and cells were fractionated into cytosolic, membrane (memb), and nuclear fractions. Abl kinase
activity was determined using an in vitro kinase assay with GST-Crk as a substrate (top). Lysates from each fraction were Western blotted
for c-Abl (bottom).
(D) Wild-type Jurkat cells, Zap70-deficient P116 cells, or Lck-deficient JCam1 cells were stimulated, and Abl kinase activity was assayed as
in (A).
C1 (PLC1) recruited to LAT. Further, TCR-dependent results obtained with the related Crk protein [9, 10]. We
next examined the activity of the c-Abl kinase directlytyrosine phosphorylation of PLC1 was decreased in
the absence of Abl kinase activity, leading to a reduction using GST-Crk as a substrate in an in vitro kinase assay
[12]. We found that while c-Abl was highly expressed inin the TCR-induced activation of ERK. Significantly, we
show decreased IL-2 production and cell proliferation the nucleus, only the membrane-associated fraction
was activated following TCR activation (Figure 1C).in response to TCR stimulation in primary T cells lacking
functional Abl tyrosine kinases. These results are similar to those previously described
for activation of the Abl kinases downstream of the
PDGF receptor [12].Results
We have previously shown that Abl kinases are acti-
vated following stimulation of the PDGF receptor in aAbl Tyrosine Kinases Are Activated
Src-dependent manner [12]. To determine whether aby TCR Engagement
similar mechanism of activation is employed down-We first examined whether stimulation of the TCR could
stream of the TCR, we examined the activation of Ablactivate the endogenous Abl kinases. To this end, we
kinases in Jurkat lines lacking the Src-family kinase Lckanalyzed the phosphorylation status of the endogenous
(JCam1) [13] or the tyrosine kinase Zap70 (P116) [14].Abl substrate CrkL by using a phosphospecific antibody
Activation of TCR signaling in wild-type and P116 butdirected against the conserved tyrosine phosphorylated
not JCam1 Jurkat cells resulted in activation of the Ablby the Abl kinases in the Crk/CrkL family of adaptor
kinases (Figure 1D). We also confirmed that the Abl-proteins [9, 10]. Phosphorylation of Crk at this site is
specific site in CrkL (Y207) is not a target for phosphory-abrogated in fibroblasts null for c-Abl and Arg [9]. The
lation by either Syk or Lck, demonstrating that theselevel of phospho-CrkL was elevated within 5 min of re-
kinases are not directly involved in the phosphorylationceptor stimulation and was maintained up to 10 min
of CrkL Y207 following TCR stimulation (Figure S2).post-stimulation (Figure 1A). To demonstrate that the
Taken together, these data demonstrate that the mem-phosphorylation of CrkL at this site was dependent on
brane-associated Abl kinases are activated followingAbl kinase activity, we treated Jurkat cells prior to activa-
TCR stimulation in an Lck- but not Zap70-dependenttion with the specific Abl kinase inhibitor STI-571 (also
manner.known as Gleevec or Imatinib). This compound inhibits
the Abl nonreceptor tyrosine kinases, as well as the
c-Kit and platelet-derived growth factor (PDGF) receptor Abl Kinases Regulate Transcriptional Activity
Downstream of the TCRkinases, but does not inhibit other tyrosine kinases, in-
cluding Lck, Syk, and Zap70 (Supplemental Figures S1A We next examined whether the activity of the two Abl
kinases, c-Abl and Arg, was required for regulation ofand S1B) [11]. Treatment of Jurkat T cells with STI-571
inhibited TCR-induced phosphorylation of CrkL at the signaling pathways leading to activation of IL-2 tran-
scription in response to TCR stimulation. Inhibition ofAbl-specific site (Figure 1B), in agreement with previous
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Figure 2. Abl Kinases Regulate Transcriptional Activation Downstream of the TCR
(A) Jurkat T cells transfected with the full-length IL-2 luciferase reporter plasmid were treated with the indicated concentrations of the Abl
kinase inhibitor STI-571. Cells were then left untreated (black bars) or stimulated (white bars) with anti-CD3 (1:500) and anti-CD28 (1 g/ml).
After 6 hr, cells were lysed and luciferase activity was measured.
(B) Jurkat T cells transfected with a CD28RE/AP luciferase reporter construct were treated with the indicated concentrations of the Abl kinase
inhibitor STI-571 and were then left untreated (black bars) or stimulated (white bars) with anti-CD3 (1:5000), anti-CD28 (100 ng/ml), and PMA
(20 ng/ml). Luciferase activity was determined as in (A).
(C) Jurkat T cells transfected with an NFAT luciferase reporter construct were treated with either vehicle (black bars) or the Abl kinase inhibitor
STI-571 (5 M; white bars) prior to stimulation with anti-CD3 (1:1000) or anti-CD3 plus anti-CD28 (0.2 g/ml). Luciferase activity was determined
as in (A). Results represent the average  SD of triplicate samples and are representative of four (A), two (B), or three (C) independent
experiments. An asterisk represents statistically significant inhibition of reporter activity in the presence of STI-571 relative to cells not receiving
the drug (p  0.05).
Abl kinase activity following treatment of Jurkat T cells promoter. Expression of a gain-of-function mutant of
c-Abl, AblPP [15], resulted in a statistically significant,with increasing concentrations of STI-571 (0–5 M) re-
sulted in a dose-dependent inhibition of TCR-induced dose-dependent activation of the IL-2 promoter (Figure
3A). Further, overexpression of the activated AblPP mu-transcription of a firefly luciferase gene fused to the full-
length IL-2 promoter, relative to untreated cells (Figure tant was sufficient to drive activation of the NFAT re-
porter construct (Figure 3B). Together, these data dem-2A). This range of doses is within that previously utilized
for in vivo inhibition of Abl kinases [9–11] and is sufficient onstrate that Abl kinase activity is necessary and
sufficient to drive signaling events leading to transcrip-to inhibit the TCR-induced activation of the Abl kinases
(Figure 1B). For these studies, cells were pretreated with tion of the full-length IL-2 promoter.
a concentration of 5 M rather than the higher levels
utilized for other assays, as higher concentrations of Abl Kinases Regulate Signal Transduction
Downstream of the TCRSTI-571 (10 M) resulted in decreased basal transcrip-
tion (data not shown). Inhibition of Abl kinase activity To define the role of the Abl kinases in the TCR-induced
signaling pathways leading to activation of the IL-2 pro-by treatment with 5 M STI-571 reduced TCR-induced
activation of the CD28RE/AP (Figure 2B) and NFAT (Fig- moter, we first analyzed whether loss of Abl kinase activ-
ity affected tyrosine phosphorylation of specific signal-ure 2C) response elements of the IL-2 promoter by ap-
proximately 50% and 30%, respectively, compared to ing proteins downstream of the TCR in Jurkat T cells.
Treatment with STI-571 did not result in an obvious alter-untreated cells. These results demonstrate that the ki-
nase activities of c-Abl and/or Arg are required for maxi- ation in the TCR-induced activation of Lck as deter-
mined by the total tyrosine phosphorylation status ofmal transcriptional activation of the IL-2 promoter down-
stream of TCR engagement. the TCR chain or Zap70, two Lck substrates (Figures
4A and 4B). As analysis of total tyrosine phosphorylationNext, we examined whether a constitutively active
form of the c-Abl tyrosine kinase was sufficient to induce of Zap70 may not reflect the regulation of specific sites
of phosphorylation linked to Zap70 activation [16], wesignaling pathways leading to transcription of the IL-2
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(AblPP) [15] or kinase-inactive c-Abl (AblKM) in 293T
cells. Coexpression of KD or WT Zap70 with AblPP in
these cells resulted in an increased total tyrosine phos-
phorylation of ZAP70 (data not shown) as well as phos-
phorylation of Y319 of Zap70 (Figure 5A). Low levels
of tyrosine phosphorylation were also apparent when
Zap70 was overexpressed together with the weakly acti-
vated wild-type c-Abl, but no tyrosine phosphorylation
of Zap70 was observed in the presence of kinase-inac-
tive AblKM (Figure 5A). Similarly, coexpression of LAT
with the constitutively active AblPP in 293T cells resulted
in tyrosine phosphorylation of LAT (Figure 5B). In addi-
tion, we observed low levels of tyrosine phosphorylation
of LAT in the presence of the weakly activated wild-type
c-Abl but not the kinase-inactive AblKM (Figure 5B). To
address whether LAT is a direct substrate of the Abl
kinases, we examined whether Abl kinases could phos-
phorylate a purified GST-LAT protein in vitro. LAT was
phosphorylated by wild-type c-Abl and the activated
AblPP but not by the kinase-inactive AblKM (Figure 5C).
No tyrosine phosphorylation of GST was observed (data
not shown). These results suggest that the Zap70 tyro-
sine kinase and the LAT adaptor protein may be direct
cellular substrates of the Abl tyrosine kinases.
Figure 3. Abl Kinases Are Sufficient to Activate Transcription of the Inhibition of Abl Kinases Impairs Binding of PLC
IL-2 Promoter and the NFAT Binding Element to LAT and Its Subsequent Activation
Jurkat cells were cotransfected with the IL-2 (A) or NFAT (B) reporter Following TCR-induced tyrosine phosphorylation, LAT
plasmids, the indicated amount of pSGT AblPP, and -actinin associates with a number of proteins, including PLC1
-galactosidase plasmid. Results represent the average  SD of [8]. Binding of PLC1 to LAT is required for the tyrosine
relative light units (RLU) determined from triplicate samples and are
phosphorylation and activation of PLC1 [8, 19]. Ourrepresentative of at least three independent experiments (left). The
finding that STI-571 treatment inhibited TCR-inducedlevel of AblPP expression was determined by Western blot analysis
(right). An asterisk represents statistically significant activation of transcription from the NFAT and CD28RE/AP promoters
reporter activity in the presence of AblPP relative to cells transfected (Figure 2), which requires activation of PLC1 [20], to-
with vector (p  0.05). gether with our previous finding that PLC1 and c-Abl
are functionally linked downstream of the PDGF recep-
tor [21], led us to examine whether inhibition of Abl
kinases affected PLC1 signaling in T cells. STI-571examined the TCR-induced phosphorylation of one of
treatment of Jurkat T cells prior to TCR activation re-the autophosphorylation sites of Zap70, tyrosine 319
duced the recruitment of PLC1 to LAT (Figure 6A) and(Y319). The phosphorylation of this site, which is impor-
decreased the tyrosine phosphorylation of PLC1 (Fig-tant for the recruitment of SH2-domain-containing pro-
ure 6B). Activation of PLC1 contributes to TCR-inducedteins to Zap70 [16, 17], was inhibited in the presence of
ERK activation [7]. Thus, as expected, inhibition of AblSTI-571 (Figure 4C). These results suggest that the ki-
kinases in Jurkat cells reduced the levels of phospho-nase activity of Zap70 is altered in the presence of STI-
ERK in response to TCR stimulation (Figure 6C). These571. In agreement with previously published data, we
results demonstrate that Abl kinases are required fordid not observe direct inhibition of Zap70 or Syk kinase
the recruitment and maximal tyrosine phosphorylationactivities by STI-571 (Figures S1A and S1B) [11]. These
of PLC1, as well as the subsequent activation of ERKresults suggest that TCR-mediated activation of Zap70
following TCR stimulation.is at least partially dependent on Abl kinase activity.
We next examined whether inhibition of Abl kinases
affected the phosphorylation of LAT, a downstream sub- Loss of Abl/Arg Kinase Activity Impairs
TCR-Induced Signaling, IL-2 Production,strate of Zap70 [18]. Analysis of LAT immunoprecipitates
revealed that, indeed, TCR-induced tyrosine phosphor- and Proliferation in Primary T Cells
Mice lacking the c-Abl kinase exhibit several immuneylation of this protein was markedly reduced in the pres-
ence of STI-571 in Jurkat T cells (Figure 4D). These system defects, including thymic atrophy, reduction in
T cell numbers, and increased susceptibility to infectionresults demonstrate that the Abl kinases are involved in
TCR-mediated regulation of the Zap70 tyrosine kinase [3, 4]. Due to their increased susceptibility to infection,
which is notably similar to mice deficient in the TCRand downstream signaling to LAT.
We next examined whether Abl kinases could directly signaling kinase Zap70, the c-Abl null mice were main-
tained in a pathogen-free environment.induce the phosphorylation of Zap70 and LAT. To this
end, we first coexpressed kinase-defective (KD) or wild- The two Abl family kinases, c-Abl and Arg, exhibit
redundant functions during mouse development [2]. Totype (WT) Zap70 with c-Abl wild-type, kinase-active c-Abl
Current Biology
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Figure 4. Inhibition of Abl Kinases Reduces TCR-Induced Signaling through Zap70 and LAT
Jurkat T cells were either untreated or pretreated with STI-571 (5 or 10 M) 1 hr prior to stimulation with anti-CD3. Cell lysates were incubated
with anti-TCR chain (A), anti-Zap70 (B and C), or anti-LAT (D) antibodies, and immunoprecipitates were analyzed by Western blotting for
phosphotyrosine (A, B, D) or phosphorylation of Zap70 tyrosine 319 (C) (top). Blots were stripped and reprobed with the immunoprecipitating
antibody to show equal loading (bottom).
examine whether loss of Abl kinase function affected the Abl kinases was reduced an average of 40% relative
to that observed in cells from double heterozygous mice.TCR signaling in primary T lymphocytes, we analyzed
We further examined the effect of progressive loss ofT cells from Abl1/	Abl2	/	 mice. These mice were uti-
Arg protein in the context of Abl1 heterozygocity. TCR-lized because, unlike Abl1	/	Abl2	/	 mice, which die
induced cell proliferation and IL-2 secretion were bothbefore embryonic day 11, and Abl1	/	Abl2/	 mice,
significantly reduced in T cells isolated from Abl1/	which die between embryonic day 15.5 and 16, some
Abl2/	 and Abl1/	Abl2	/	 relative to those from Abl1/	Abl1/	Abl2	/	 are viable [2]. TCR-induced phosphoryla-
Abl2/ mice (Figures 8B and 8C). In contrast, PMA plustion of LAT was reduced in purified splenic T cells iso-
ionomycin-induced IL-2 production and cell prolifera-lated from Abl1/	Abl2	/	 mice relative to that observed
tion in Abl1/	Abl2	/	-derived cells were unaffectedin cells isolated from Abl1/Abl2/	 mice (Figure 7A).
compared to controls (Figures 8A and 8B, data notNext, we examined whether the enzymatic activity of
shown). These results show that signaling downstreamthe Abl family kinases is required for TCR-induced sig-
of the TCR is sensitive to loss of the Arg kinase in analing in primary T cells isolated from wild-type mice.
c-Abl heterozygous background.STI-571 treatment of primary T lymphocytes prior to
To address whether inhibition of both c-Abl and ArgTCR activation resulted in a drastic reduction in TCR-
kinase activities affects TCR-induced proliferation, puri-induced LAT tyrosine phosphorylation (Figure 7B). Fur-
fied splenic T cells isolated from wild-type mice werether, we found that the TCR-induced activation-specific
treated with increasing concentrations of STI-571 priorphosphorylation of the Zap70 and ERK kinases, as well
to stimulation with either anti-CD3 or PMA plus iono-
as the phosphorylation of the activating tyrosine of PLC
mycin. Treatment with STI-571 at doses of 5 or 10 M
(Y783), were reduced in splenic T cells isolated from markedly reduced [3H]thymidine incorporation in anti-
Abl1/	Abl2	/	 mice relative to that observed in these CD3-treated cells by an average of 70% and 97%, re-
cells from Abl1/Abl2/ mice (Figures 7C–7E). The ac- spectively (Figure 8D). Further, we observed a 90% re-
tivation of ERK and the phosphorylation of PLC Y783 duction in anti-CD3-induced IL-2 production by primary
in the Abl1/	Abl2	/	-derived T cells were reduced rela- T lymphocytes treated with 10 M STI-571 compared
tive to those from wild-type mice up to 30 min post- to untreated cells (Figure 8E). These results were not
stimulation (Figures 7D and 7E). These findings demon- due to STI-571-induced toxicity or a general defect in
strate that reduction of Abl/Arg protein expression, as proliferation, since STI-571 did not inhibit proliferation
well as pharmacological inhibition of Abl kinase activity, of or IL-2 production by cells activated with PMA plus
inhibits the TCR-induced signal transduction through ionomycin (Figure 8D and data not shown). Together,
the Zap70-LAT-ERK pathway in primary T lymphocytes. these results demonstrate that loss of endogenous Abl
We next analyzed whether deletion and/or inhibition kinase function causes a profound decrease in IL-2 pro-
of Abl kinases play a role in TCR-induced proliferation. duction, leading to a reduction in the proliferation of
Purified splenic T cells from Abl1/	Abl2/	 and Abl1/	 primary T cells following TCR activation.
Abl2	/	 littermates were activated by treatment with anti-
CD3 or phorbol myristic acid (PMA) plus ionomycin, Discussion
and cell proliferation was analyzed by [3H]-thymidine
incorporation (Figure 8A). The proliferative capacity of In this report, we have uncovered a novel role for the
Abl family kinases in TCR-induced IL-2 production andT cells isolated from mice retaining only one allele of
Abl Kinases Regulate TCR Signaling
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Figure 6. TCR-Induced Association of PLC1 with LAT and Down-
Figure 5. Zap70 and LAT Are Phosphorylated by Abl stream Signaling to ERK Are Reduced in the Presence of the Abl
(A) 293T cells were transfected with cDNAs encoding kinase-defec- Inhibitor STI-571
tive (KD) or wild-type (WT) Zap70 and either vector (-) or plasmids Jurkat cells were either left untreated or pretreated with STI-571 1
encoding inactive (KM), wild-type, or activated (PP) forms of the hr prior to stimulation with anti-CD3.
Abl kinase. The phosphorylation of Zap70 Y319 was determined by (A) Cell lysates were immunoprecipitated with normal rabbit serum
Western blotting Zap70 immunoprecipitates with a phosphospecific (NRS) or anti-LAT antiserum. Immunoprecipitates were separated
antibody (top). The blot was stripped and reprobed using antiserum by SDS-PAGE and Western blotted for PLC1 (top). Blots were also
against Zap70 to demonstrate equal loading (middle). Levels of Abl probed with anti-LAT antiserum (bottom).
expression were analyzed in whole-cell lysates by Western blotting (B) Cell lysates were immunoprecipitated with a polyclonal anti-
(bottom). PLC1 antibody. Immunoprecipitates were analyzed for phospho-
(B) Tyrosine phosphorylation of LAT by c-Abl was analyzed in LAT tyrosine by Western blotting (top). Blots were reprobed with an anti-
immunoprecipitates of lysates from 293T transfected with Myc- PLC1 monoclonal antibody to demonstrate equal loading (bottom).
tagged LAT and the various forms of c-Abl as in (A) (top). The blot (C) The level of ERK activation in cell lysates was analyzed by West-
was stripped and reprobed using antiserum against LAT to demon- ern blotting with an antibody against active, phosphorylated ERK
strate equal loading (middle). Abl expression was analyzed as above (P-ERK) (top). Blots were stripped and reprobed with anti-ERK
(bottom). antibody to demonstrate equal loading (bottom).
(C) 293T cells were transfected with plasmids encoding the indicated
Abl variants as in (A). Cells were lysed and Abl proteins were immu-
noprecipitated and utilized in an immunocomplex kinase assay with sponds to trough plasma levels of approximately 1 M
GST-LAT (0.5 g) as the substrate. Kinase reactions were analyzed
[22]. While this dose is effective for inhibition of cellby Western blotting for phosphotyrosine (top). Blots were reprobed
growth and survival of the exquisitely sensitive Bcr-Abl-with anti-GST antibody to demonstrate equal loading of the sub-
positive leukemic cells, it is suboptimal for full inhibitionstrate (bottom).
of endogenous Abl kinase activity [9, 23]. Our findings
suggest that use of higher doses (5- to 10-fold) of STI-
571 will produce enhanced immunosuppression in CMLproliferation. These findings are consistent with reports
that implicate Abl kinases in immune responses in mice patients, due in part to more effective inhibition of the
endogenous c-Abl and Arg kinases.and men. Mice with a targeted disruption of the Abl1
gene show increased susceptibility to infection and de- Here, we show that deletion of Abl2 in an Abl1 hetero-
zygous background in the Abl1/	Abl2	/	 mice or phar-creased numbers of thymocytes and B cell progenitors
[3, 4]. Moreover, data are now accumulating that a sub- macological inhibition of both Abl kinases with STI-571
resulted in a significant reduction in T cell respon-set of CML patients treated with STI-571 become immu-
nosuppressed and develop varicella zoster virus (VZV) siveness to TCR stimulation. Splenic T cells isolated
from c-Abl- or Arg-single null animals did not show re-infection [5]. Reactivation of latent viral infection ap-
pears to be the mechanism that leads to the develop- producible decreases in TCR-dependent cell prolifera-
tion (data not shown). These results are in agreementment of VZV infection in these patients. This is likely to
be due to defects in cell-mediated immunity as a result with previous studies by others in which splenocytes
isolated from mice singly deficient for c-Abl do not dis-of low numbers of CD4-positive T cells [5]. The finding
that a subset of STI-571-treated patients are immuno- play significant deficits in responsiveness to TCR stimu-
lation [24], and that Arg null mice do not exhibit anysuppressed is highly significant given that the standard
clinical dose of STI-571 (Imatinib) (400 mg/day) corre- obvious immunologic deficits [2]. These results are con-
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Figure 7. Abl Kinases Are Required for Signaling Downstream of the TCR in Primary T Cells
(A) Primary splenic T cells were isolated from Abl1/Abl2/	 or Abl1/	Abl2	/	 mice and stimulated with anti-CD3. Whole-cell lysates were
analyzed for tyrosine phosphorylation (top) and LAT (bottom) by Western blotting. The migration of molecular weight markers is indicated on
the right.
(B) Purified splenic T cells isolated from wild-type mice were left untreated or were pretreated with STI-571 for 1 hr prior to stimulation with
plate-bound anti-CD3. Cells lysates were analyzed for phosphotyrosine (top) and LAT (bottom) by Western blotting. The migration of molecular
weight markers is indicated on the right.
(C) Primary splenic T cells were isolated from the indicated mice as in (A), and the phosphorylation of Zap70 Y319 was assessed by Western
blotting using phosphospecific antibodies to this tyrosine (top). Blots were stripped and reprobed with anti-Zap70 antiserum to show equal
loading (bottom).
(D and E) Primary splenic T cells were isolated from the indicated mice as in (A) and stimulated for up to 30 min with anti-CD3 antibody. The
activation states of ERK (D) and PLC (E) were assessed by Western blotting using phosphospecific antibodies to the active forms of these
enzymes (top). Blots were stripped and reprobed to show equal loading with the indicated antibodies (bottom).
sistent with the observation that c-Abl and Arg play roles [25]. Similarly, single deletion of Zap70 results in
an immunocompromised phenotype but does not com-redundant roles during mouse development [2]. The
c-Abl protein is ubiquitously expressed, while Arg is pletely abrogate signaling in T cells of all lineages, sug-
gesting that the Syk tyrosine kinase may have a compen-most highly expressed in the brain, thymus, and spleen
[1]. Thus, Arg is likely to have redundant functions with satory role in some T cell lineages [26]. Together, these
studies emphasize the existence of functional redun-c-Abl in T lymphocytes. Interestingly, unlike B lympho-
cyte signaling, which is susceptible to loss of c-Abl alone dancy and/or compensatory roles for various tyrosine
kinase families activated downstream of the TCR.[6], we have shown here that both c-Abl and Arg play
important and redundant roles in T lymphocyte sig- Activation of the TCR leads to stimulation of the Src
family kinases, including Lck [7]. We show here thatnaling.
The redundant functions of the c-Abl and Arg kinases c-Abl is activated in an Lck-dependent manner (Figure
1). This mechanism is similar to that we and othersare similar to those observed in mice null for other tyro-
sine kinases that function downstream of the TCR. Dele- previously reported for activation of c-Abl downstream
of growth factor receptors, which requires the activitytion of Fyn alone causes no obvious TCR signaling de-
fects, and deletion of Lck results in a partial block of of Src family kinases [1, 12, 27]. Once activated, Abl
kinases induce phosphorylation of Zap70. LAT is thenthymocyte development but does not completely abro-
gate TCR-induced signaling in thymocytes and primary phosphorylated by Zap70, resulting in the recruitment
of several proteins, including PLC1 [24], which is phos-T cells [25]. In contrast, deletion of both kinases com-
pletely arrestsT cell development at the double nega- phorylated on Y783 to induce PLC1 activation leading
to the production of IP3 and DAG [8]. The productiontive stage, indicating that these kinases play redundant
Abl Kinases Regulate TCR Signaling
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Figure 8. Abl Kinases Are Required for Cell Proliferation and IL-2 Production in Response to TCR Stimulation of Primary T Cells
(A and B) Primary T cells were purified from spleens isolated from mice with the indicated genotypes and stimulated with medium alone,
plate bound anti-CD3 (0.5 g/ml), or PMA (5 ng/ml) plus ionomycin (250 ng/ml) for 48 hr. Results represent the mean incorporation of
[3H]thymidine  SD of triplicate samples and are representative of three independent experiments.
(C) Primary splenic T cells of the indicated genotypes were analyzed for IL-2 secretion by ELISA. Results are expressed as the ratio of IL-2
produced in cells stimulated with anti-CD3 to that from cells maximally stimulated with PMA plus ionomycin  SD of triplicate samples.
Results are representative of three independent experiments.
(D) Purified splenic T cells isolated from wild-type mice were treated with vehicle or increasing doses of STI-571 1 hr prior to stimulation as
in (A). Results represent the mean incorporation of [3H]thymidine  SD of triplicate samples and are representative of four independent
experiments.
(E) Purified splenic T cells were isolated from wild-type mice and treated with the indicated doses of STI-571 prior to stimulation with plate-
bound anti-CD3 for 24 hr. IL-2 secretion into cell supernatants was determined by ELISA and expressed as described in (C)  SD of duplicate
samples. Results are representative of three independent experiments. An asterisk represents statistically significant differences in data (p  0.05).
of DAG, as well as activation of other LAT-dependent adaptor function for the recruitment of signal transduc-
ers and regulators to the Zap70 signaling complex [16,signaling complexes, leads to ERK activation. Ulti-
mately, activation of these signaling molecules leads to 30]. Interestingly, the sequences downstream of Y319
match the consensus phosphorylation and SH2-domainactivation of the IL-2 promoter, resulting in IL-2 produc-
tion and cell proliferation [8]. binding sequence for the Abl kinases (YXXP) [31, 32].
Thus, Abl kinases may both phosphorylate and bindIn this report, we place the Abl kinases as novel inter-
mediates in the regulation of the Zap70 tyrosine kinase Zap70 at Y319, as it is known that the SH2 domains of
kinases often interact with their phosphorylation sitesvia phosphorylation of Y319. TCR-dependent regulation
of Zap70 function by tyrosine phosphorylation is com- [31, 32]. Indeed, the Abl SH2 domain interacts with phos-
phorylated Zap70, and Abl associates with Zap70 fol-plex and has both positive and negative roles [28]. Y319
is located in the interdomain B region of the kinase and lowing TCR stimulation [29]. The Abl kinases may also
associate with Zap70 indirectly via interaction with thehas been reported to be autophosphorylated following
TCR activation [16, 29, 30]. However, trans-phosphory- Crk/CrkL proteins, which bind Zap70 and Abl via their
SH2 and SH3 domains, respectively [33, 34]. Upon asso-lation by other kinases has not been ruled out. While
the precise contribution of Y319 phosphorylation to reg- ciation, Abl may regulate Zap70 function by (1) trans-
phosphorylating Y319 (and possibly other tyrosines), (2)ulation of Zap70 catalytic activity remains controversial,
phosphorylation of this tyrosine serves an important competing for binding with other SH2 domain-con-
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